Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
U.D. Allen, L. Navas, S.M. King.
Effectiveness of intrapartum penicillin prophylaxis in preventing earlyonset group B streptococcal infection: results of a meta-analysis.
Can Med Assocj, 149 (1993), pp. 1659-1665
[2.]
S.R. Allen.
Management of asymptomatic term neonates whose mothers received intrapartum antibiotics. Part 1: Rationale for intrapartum antibiotic therapy.
Clin Pediatr, 36 (1997), pp. 563-568
[3.]
S.R. Allen.
Management of asymptomatic term neonates whose mothers received intrapartum antibiotics (II): Diagnostic tests and management strategies.
Clin Pediatr, 36 (1997), pp. 617-624
[4.]
American College of Obstetrics and Gynecologists.
Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion 279. December 2002.
Obstet Gynecol, 100 (2002), pp. 1405-1412
[5.]
A. Andreu, M. Barranco, J. Bosch, E. Dopico, C. Guardia, T. Juncosa, et al.
Prevention of perinatal group B streptococcal disease in Europe.
Scand J Infect Dis, 29 (1997), pp. 532
[6.]
A. Andreu, E. Ortega, A. Planes, S. Salcedo.
Evolución de la sepsis perinatal por Escherichia coli en la era de la profilaxis del estreptococo de grupo B.
Med Clin (Barc), 117 (2001), pp. 521-524
[7.]
A. Andreu, I. Sanfeliu, L. Viñas, M. Barranco, J. Bosh, E. Dopico, et al.
Declive de la Incidencia de la sepsis perinatal por estreptococo del grupo B-Barcelona 1994-2001-Relación con las políticas profilácticas.
Enf Infec Microbiol Clin, 21 (2003), pp. 174-179
[8.]
B. Aracil, M. Miñambres, J.C. Oteo, M. De la Rosa, J.L. Gomes-Garces, J.I. Alos.
Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamines, phenotypic patterns and resistance genes.
Clin Microbiol Infect, 8 (2002), pp. 745-748
[9.]
C.J. Baker, M.S. Edwards.
Streptococcus agalactiae (group B streptococcus).
Principles and practice of infectious diseases, 5th. ed, pp. 2156-2167
[10.]
R.S. Baltimore, S.M. Huie, J.I. Meek, A. Schuchat, K.L. O'Brien.
Early-onset neonatal sepsis in the era of group B streptococcal prevention.
Pediatrics, 108 (2001), pp. 1094-1098
[11.]
M.A. Blanco Galán.
Microbiología de la infección perinatal.
Procedimientos en microbiología clínica. N.o 13. Sociedad Española de Enfermedades infecciosas y Microbiología Clínica,,
[12.]
S.J. Bliss, S.D. Manning, P. Tallman, C.J. Baker, M.D. Pearlman, C.F. Marrs, et al.
Group B streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study.
Clin Infect Dis, 15 (2002), pp. 184-190
[13.]
J. Bosch, A. Pericot, M. Amorós, R. Ros.
Endometritis puerperal: estudio de 52 casos con diagnóstico clínico y microbiológico.
Enferm Infec Microbiol Clin, 13 (1995), pp. 203-208
[14.]
J. Bosch Mestres, A. Palau Charles, L. Serra Azuara, E. Álvarez Domínguez, M.C. Ricart Costa, R. Ros Vallverdu, et al.
Sepsis neonatal precoz por Streptococcus agalactiae. Estudio de diez años (1985-1994) y eficacia de la profilaxis intraparto.
An Esp Pediatr, 46 (1997), pp. 272-276
[15.]
K.M. Boyer, S.P. Gotoff.
Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.
N Engl J Med, 314 (1986), pp. 1665-1669
[16.]
P. Bromberger, J.M. Lawrence, D. Braun, B. Saunders, R. Contreras, D.B. Petitti.
The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants.
Pediatrics, 106 (2000), pp. 244-250
[17.]
Centers for Disease Control and Prevention.
Group B streptococcal disease.United States,1998-1999.
Mmwr, 49 (2000), pp. 793-796
[18.]
K.T. Chen, R.E. Tuomala, A.P. Cohen, E.C. Eichenwald, E. Lieberman.
No increase in rates of early-onset neonatal sepsis by nongroup B Streptococcus or ampicillin-resistant organisms.
Am J Obstet Gynecol, 185 (2001), pp. 854-858
[19.]
M. Cueto, M.J. Sánchez, L. Molto, J.A. Miranda, A.J. Herruzo, A. Ruiz Bravo, et al.
Efficacy of a universal screening program for the prevention of neonatal group B streptococcal disease.
Eur J Clin Microbiol Infect Dis, 14 (1995), pp. 810-812
[20.]
M. Cueto, M.J. Sánchez, A. Sampedro, J.A. Miranda, A.J. Herruzo, M. De la Rosa-Fraile.
Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus.
Obstet Gynecol, 91 (1998), pp. 112-114
[21.]
M.S. Edwards, C.J. Baker.
Group B streptococcal infections.
Infectious diseases of the fetus & newborn infant, 5th ed, pp. 1091-1096
[22.]
D.R. Feikin, P. Thorsen, S. Zywicki, M. Arpi, J.G. Westergaard, A. Schuchat.
Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women.
Am J Obstet Gynecol, 184 (2001), pp. 427-433
[23.]
Food and Drug Administration.
FDA safety alert: Risks of devices for direct detection of group B streptococcal antigen, (March 24, 1997),
[24.]
E. García Gil, M.C. Rodríguez, R. Bartolomé, B. Bejarano, L. Cabero, A. Andreu.
Evaluation of the Granada agar plate for detection of vaginal and rectal group B streptococci in pregnant women J Clin Microbiol, 37 (1999), pp. 2648-2651
[25.]
S.E. Gardner, M.D. Yow, L.J. Leeds, P.K. Thompson, E.O. Mason Jr., D.J. Clark.
Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study.
Am J Obstet Gynecol, 135 (1979), pp. 1062-1065
[26.]
S.M. Garland, J.R. Fliegner.
Group B streptococcus (GBS) and neonatal infections: the chase for intrapartum chemoprophylaxis.
Aust N Z Obstet Gynaecol, 31 (1991), pp. 119-122
[27.]
GEIP (Grupo de Estudio SEIMC de la Infeccion Perinatal).
Resultados del estudio multicéntrico de sensibilidades de estreptococo grupo B. Comunicación personal.
Reunion SEIMC,
[28.]
G.J. Gilson, F. Christensen, H. Romero, K. Bekes, L. Silva, C.R. Qualls.
Prevention of group B streptococcus early-onset neonatal sepsis: comparison of the Center for Disease Control and prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks?f gestation.
J Perinatol, 20 (2000), pp. 491-495
[29.]
Grupo Castrillo.
Estudio incidencia sepsis neonatal en los hospitales espanoles [comunicacion personal], (2003),
[30.]
R.T. Hall, W. Barnes, L. Krishnan, D.J. Harris, P.G. Rhodes, J. Fayez, et al.
Antibiotic treatment of parturient women colonized with group B streptococci.
Am J Obstet Gynecol, 124 (1976), pp. 630-634
[31.]
Y. Hennequin, L. Tecco, A. Vokaer.
Use of chlorhexidine during labor: How effective against neonatal group B streptococci colonization?.
Acta Obstet Gynaecol Scand, 74 (1995), pp. 168
[32.]
H.S. Jafari, A. Schuchat, R. Hilsdon, C.G. Whitney, K.E. Toomey, J.D. Wenger.
Barriers to prevention of perinatal Group B streptococcal disease.
Pediatr Infect Dis J, 14 (1995), pp. 662-667
[33.]
H.E. Jeffery, M. Moses Lahra.
Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers.
Pediatrics, 101 (1998), pp. 2E
[34.]
T. Juncosa, J. Bosh, E. Dopico, C. Guardia, J. Lite, M. Sierra, et al.
Infeccion neonatal por Streptococcus agalactiae. Estudio multicentrico en el area de Barcelona.
Enf Infec Microbiol Clin, 16 (1998), pp. 312-315
[35.]
E.L. Kaplan.
Recent evaluation of antimicrobial resistance in Β-hemolytic streptococci.
Clin Infec Dis, 24 (1997), pp. 89-92
[36.]
D. Ke, M.G. Bergeron.
Molecular methods for rapid detection of group B streptococci.
Expert Rev Mol Diagn, 1 (2001), pp. 175-181
[37.]
E.M. Levine, C.M. Strom, V. Ghai, J.J. Barton.
Intrapartum management relating to risk of perinatal transmission of group B streptococcus.
Infect Dis Obstet Gynecol, 6 (1998), pp. 25-29
[38.]
E.M. Levine, V. Ghai, J.J. Barton, C.M. Strom.
Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis.
Infect Dis Obstet Gynecol, 7 (1999), pp. 210-213
[39.]
J.B. Lopez Sastre, G.D. Coto Cotallo, B. Fernandez Colomer.
Neonatal sepsis of vertical transmission, y epidemiological study from the Grupo de Hospitales Castrillo.
J Perinat Med, 28 (2000), pp. 309-315
[40.]
J.B. Lopez Sastre, M. Sanchez Luna, B. Fernandez Colomer, G.D. Coto Cotallo.
y Grupo de Hospitales Castrillo. Impact of antimicrobial prophylaxis in the epidemiology of vertical transmission sepsis.
GBS neonatal disease symposium. Granada, (November 2002),
[41.]
R. Matorras, A. Garcia Perea, F. Omenaca, J.A. Usandizaga, A. Nieto, R. Herruzo.
Group B Streptococcus and premature rupture of membranes and preterm delivery.
Gynecol Obstet Invest, 27 (1989), pp. 14-18
[42.]
A. Mazon, M.S. Salvo, R. Ezcurra.
Resultados del programa de prevencion de la infeccion neonatal por estreptococo del grupo B.
Prog Obstet Ginecol, 43 (2000), pp. 233-236
[43.]
P.B. Mead.
Infection of the female pelvis.
Priciples and practice of infectious diseases, 5th ed, pp. 1235-1243
[44.]
M. Moller, A.C. Thomsen, K. Borch, K. Dinesen, M. Zdravkovic.
Rupture of membranes and premature delivery associated with group B streptococci in urine of pregnant women.
Lancet, 2 (1984), pp. 69-70
[45.]
L.C. Paoletti, L. Madoff.
Vaccines to prevent neonatal GBS infection.
Seminars Neonatology, 7 (2002), pp. 315-323
[46.]
K. Persson, B. Bjerre, L. Elfstrom, S. Polberger, A. Forsgren.
Group B streptococci at delivery: high counts in urine increases risk for neonatal colonization.
Scand J Infect Dis, 18 (1986), pp. 525-531
[47.]
J.A. Regan, A. Klebanoff, R.P. Nugent, Vaginal Infection and Prematurity Study Group.
The epidemiology of group B colonization in pregnancy.
Obstet Gynecol, 77 (1991), pp. 604-610
[48.]
J.A. Regan, M.A. Klebanoff, R.P. Nugent, D.A. Eschenbach, W.C. Blackwelder, Y.S. Yu Lou, et al.
VIP Study Group Colonization with group B streptococci in pregnancy and adverse outcome.
Am J Obstet Gynecol, 174 (1996), pp. 1354-1360
[49.]
M. Rosa, D. Villarreal, D. Vega, C. Miranda.
Martinez Brocal Granada Medium for detection and identification of Group B streptococci.
J Clin Microbiol, 18 (1983), pp. 779-785
[50.]
M. Rosa, M. Perez, C. Carazo, J.I. Peis, L. Pareja, L. Hernandez.
New Granada Medium for detection and Identification of group B streptococci.
J Clin Microbiol, 30 (1992), pp. 1019-1021
[51.]
M. Rosa-Fraile, J. Rodriguez-Granger, M. Cueto-Lopez, A. Sampedro, E. Biel Gaye, J.M. Haro, et al.
Use of Granada Medium to detect group B streptococcal colonization in pregnant women.
J Clin Microbiol, 37 (1999), pp. 2674-2677
[52.]
R. Samadi, A. Stek, J.S. Greenspoon.
Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients.
J Matern Fetal Med, 10 (2001), pp. 203-208
[53.]
S.J. Schrag, S. Zywicki, M.M. Farley, A.L. Reingold, L.H. Harrison, L.B. Lefkowitz, et al.
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
N Engl J Med, 342 (2000), pp. 15-20
[54.]
S.J. Schrag, E.R. Zell, R. Lynfield, A. Roome, K.E. Arnold, A.S. Craig, et al.
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.
N Engl J Med, 347 (2002), pp. 233-239
[55.]
S. Schrag, R. Gorwitz, K. Fultz-Butts, A. Schuchat.
Prevention of perinatal group B streptococcal disease. Revised Guidelines from CDC.
Mmwr, 51 (2002), pp. 1-22
[56.]
A. Schuchat.
Group B streptococcus.
Lancet, 353 (1999), pp. 51-56
[57.]
A. Schuchat, S.S. Zywicki, M.J. Dinsmoor, B. Mercer, J. Romaguera, M.J. O?fSullivan, et al.
Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study.
Pediatrics, 105 (2000), pp. 21-26
[58.]
J.D. Siegel, N.B. Cushion.
Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth.
Obstet Gynecol, 87 (1996), pp. 692-698
[59.]
Sociedad Española de Obstetricia y Ginecología. Recomendaciones para la prevención de la infección perinatal por estreptococo grupo B.
Prog Obstet Ginecol, 41 (1998), pp. 431-435
[60.]
B.J. Stoll, N. Hansen, A.A. Fanaroff, L.L. Wright, W.A. Carlo, R.A. Ehrenkranz, et al.
Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants.
N Engl J Med, 347 (2002), pp. 240-247
[61.]
B. Stray-pedersen, T. Bergan, A. Hafstad, E. Normann, J. Grogaard, M. Vangdal.
Vaginal disinfection with chlorhexidine during childbirth.
Int J Antimicrob Agents, 12 (1999), pp. 245-251
[62.]
C.V. Towers, M.H. Carr, G. Padilla, T. Asrat.
Potential consequences of widespread use of ampicillin.
Am J Obstet Gynecol, 179 (1998), pp. 879-883
[63.]
C.G. Whitney, B.D. Plikaytis, W.S. Gozansky, J.D. Wenger, A. Schauchat.
Prevention practices for perinatal group B streptococcal disease: A multi-state surveillance analysis.
Obstet Gynecol, 89 (1997), pp. 28-32
[64.]
M.K. Yancey, P. Duff, P. Clark, T. Kurtzer, B.H. Frentzen, P. Kubilis.
Peripartum infection associated with vaginal group B streptococcal colonization.
Obstet Gynecol, 84 (1994), pp. 816-819
[65.]
M.K. Yancey, A. Schuchat, L.K. Brown, V.l. Ventura, G.R. Markenson.
The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery.
Obstet Gynecol, 88 (1996), pp. 811-815
Copyright © 2003. Sociedad Española de Ginecología y Obstetricia